Syngene names Sibaji Biswas as its new CFO
Global research organization Syngene International Limited has appointed Sibaji Biswas as Chief Financial Officer and member of the Executive Committee with effect from December 18, 2019. He will succeed M.B. Chinappa, current CFO, who will stay within the Biocon Group of Companies and join Biocon Biologics India Ltd. in a new role.
Jonathan Hunt, CEO, Syngene International stated, “We are delighted to welcome Sibaji to Syngene. He brings operational experience combined with a deep finance background which will be extremely valuable to the company as it enters the next phase of growth.”
Sibaji Biswas, an alumnus of IIT Kharagpur brings more than twenty years of extensive experience in finance and related functions. His prior experience includes eleven years at Vodafone as well as roles in Fascel Telecommunications, Jhagadia Copper and the ABP Group. In his most recent role, he was CFO and Board Member for Vodafone Romania.
It is this extensive experience which Syngene, the contract research arm of Biocon, is hoping to leverage. The BSE listed company with its 4,000 strong team of scientists counts world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife among its clientele.